X @Bloomberg

IPO Plans - Argo Biopharmaceutical, a Chinese biotech firm, is planning a Hong Kong IPO [1] - The IPO could potentially raise a few hundred million US dollars [1] Financial Institutions - Argo Biopharmaceutical has selected banks to manage the Hong Kong IPO [1]